GLP-1 Weight Loss Drug Enforcement in 2025: State Attorneys General Step into a Growing Regulatory Gap The rapid rise of GLP-1 weight loss drugs such as semaglutide and tirzepatide has created two parallel markets
This tool is based on findings from Su et al., Nature 2026
Even-Looking Skin Tone: Helps reduce the appearance of uneven pigmentation, dark spots, and tired-looking skin over time
Focus on the positives that you are taking steps to improve your lifestyle and lose weight a positive mindset will do wonders for your progress
It's important to note that GLP-1 medications are not recommended for people with severe gastrointestinal disease, including severe gastroparesis, as they may worsen symptoms
Many researchers agree that GLP-1RA may be potentially beneficial for patients with neurological diseases, regardless of its glucose-modulating effects [6]